Benefits
Brain Health and Mood Regulation
B6 helps produce neurotransmitters like serotonin and dopamine, which regulate mood and may reduce symptoms of depression and anxiety. It also supports cognitive function and may lower the risk of cognitive decline.
Red Blood Cell Formation
It aids in hemoglobin production, which carries oxygen in the blood, helping prevent anemia and improve energy levels.
Immune System Support
B6 is essential for producing immune cells and antibodies, strengthening the body’s defense against infections.
Heart Health
It helps regulate homocysteine levels, an amino acid linked to heart disease when elevated, potentially reducing cardiovascular risk.
Reduces Nausea
B6 is often used to alleviate nausea, particularly during pregnancy (morning sickness) or chemotherapy.
Hormone Balance
It may ease premenstrual syndrome (PMS) symptoms by influencing hormone regulation.
Metabolism and Energy
B6 supports the breakdown of proteins, fats, and carbohydrates, aiding energy production and nutrient utilization.
Mechanism of action
Neurotransmitter Synthesis (Brain Health and Mood)
PLP is a cofactor for enzymes like aromatic L-amino acid decarboxylase, which converts 5-hydroxytryptophan to serotonin and L-DOPA to dopamine. These neurotransmitters regulate mood, sleep, and cognitive function. It also supports glutamate decarboxylase, which produces GABA, an inhibitory neurotransmitter that promotes calmness and reduces anxiety.
Hemoglobin Synthesis (Red Blood Cell Formation)
PLP is a cofactor for aminolevulinic acid synthase, the rate-limiting enzyme in heme synthesis. Heme is a critical component of hemoglobin, enabling oxygen transport in red blood cells.
Immune Function
PLP supports the synthesis of lymphocytes and interleukins, key immune system components, by facilitating protein metabolism and nucleic acid synthesis. It enhances the production of histamine, which is involved in immune responses.
Homocysteine Regulation (Heart Health)
PLP acts as a cofactor for cystathionine β-synthase and cystathionine γ-lyase, enzymes in the transsulfuration pathway that convert homocysteine to cysteine. This reduces homocysteine levels, a risk factor for cardiovascular disease.
Nausea Reduction
The exact mechanism for B6’s anti-nausea effects (e.g., in morning sickness) is not fully understood but may involve its role in neurotransmitter balance, particularly serotonin, which influences the vomiting center in the brain.
Hormone Modulation (PMS Relief)
PLP modulates steroid hormone receptor activity, reducing the effects of estrogen excess, which may alleviate PMS symptoms like irritability and bloating.
Metabolism (Energy Production)
PLP is a cofactor for enzymes like transaminases (e.g., alanine aminotransferase), which facilitate amino acid metabolism, and glycogen phosphorylase, which breaks down glycogen for energy. It also aids in lipid and carbohydrate metabolism by supporting enzyme activity in these pathways.
Clinical trials
Double-blind, randomized, placebo-controlled trial at University of Reading, UK, in 478 young adults receiving 100 mg/day vitamin B6 vs vitamin B12 vs placebo for 1 month. Outcomes: anxiety, depression, visual processing. (Hum Psychopharmacol)
478 young adults.
B6 modestly reduced self-reported anxiety scores vs placebo. Critical caveat: 100 mg/day B6 exceeds UL — chronic use risks peripheral neuropathy (sensory neuropathy from megadose B6, reversible if caught early but permanent at high cumulative doses). The 'high-dose B6 for anxiety' marketing should be tempered by toxicity risk.
Evidence review of 25 clinical trials evaluating vitamin B6 (up to 100 mg/day) for PMS symptoms.
Pooled across PMS clinical trials.
B6 modestly improved PMS symptoms vs placebo. Royal College of Obstetricians (RCOG) endorses 50-100 mg/day B6 for PMS. Note: chronic high-dose B6 (>100 mg/day) carries neuropathy risk; lowest effective dose preferred.
2014 evidence review of clinical trials evaluating vitamin B6 for nausea and vomiting of pregnancy (NVP/morning sickness).
Pooled across NVP trials.
B6 modestly reduced nausea severity vs placebo. Critical context: B6 + doxylamine (Diclegis® / Bonjesta® / Diclectin) is FDA-approved as first-line pharmacotherapy for NVP — established; widely used and safe in pregnancy. ACOG guidelines support.
Evidence review (PRISMA) of 7 studies on pyridoxine adjunct for movement disorders/akathisia from antipsychotics.
Pooled across psychiatric adjunct trials.
Modest signals on tardive dyskinesia, akathisia. Adjunctive role; not standard care.
Double-blind, placebo-controlled clinical trial in patients with bipolar I in acute mania receiving B6 adjunct to lithium vs placebo + lithium.
Bipolar I acute mania patients.
Modest signal for B6 adjunct in mania. Note: bipolar treatment requires psychiatric specialist care; mood stabilizers (lithium, valproate, atypical antipsychotics) are foundational; supplements adjunctive at most.